New Therapies on the Horizon for Preventing the Progression of Chronic Kidney Disease in Childhood

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Çocuk Dergisi
Volume:23 Issue:4
New Therapies on the Horizon for Preventing the Progression of Chronic Kidney Disease in Childhood

New Therapies on the Horizon for Preventing the Progression of Chronic Kidney Disease in Childhood

Authors : Siobhan Wagner, Isabella Tso, Damien Noone

Pages : 369-378

Doi:10.26650/jchild.2023.1392310

View : 33 | Download : 70

Publication Date : 2024-02-20

Article Type : Review Paper

Abstract :The purpose of the review is to summarize the current pharmacological management of chronic kidney disease (CKD) in pediatric patients and critically present emerging evidence for the use of mineralocorticoid receptor antagonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors. Globally, CKD is the 19th leading cause of years of life lost and the current total number of children and adolescents affected with CKD Stages II-V is predicted to exceed 2 million in a global population of 2 billion children. The severity of kidney disease is strongly correlated with the extent of proteinuria. Agents that target the renin-angiotensin-aldosterone-system reduce proteinuria in mild to moderate CKD, slowing disease progression. Recent clinical trials evaluating mineralocorticoid receptor antagonists, such as finerenone and SGLT2 inhibitors, demonstrate similar results. However, additional pediatric clinical trials are necessary to determine their complete therapeutic potential.
Keywords : Chronic Kidney Disease, RAAS, SGLT2 Inhibitors

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.